Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Infection
97%
Therapeutic Procedure
50%
Antibiotics
29%
Antiinfective Agent
21%
Metronidazole
20%
Clinical Trial
16%
Infectious Disease Treatment
16%
Diseases
15%
Spore
14%
Kidney Injury
12%
Systematic Review
12%
Immunocompromised Patient
12%
Gastrointestinal Infection
12%
Antimicrobial Therapy
12%
Broad-Spectrum Antibiotic
12%
Tazobactam
12%
Retrospective Study
12%
Ambulatory Care
12%
Recurrent Disease
12%
Ceftolozane
12%
Next Generation Sequencing
12%
Fulminant
12%
Antibiogram
12%
Carbapenem
12%
Vaborbactam
12%
Relebactam
12%
Gut Microbiota
12%
Toxoid
12%
Vancomycin
11%
Dysbiosis
8%
Microbiome
8%
Clindamycin
6%
Quinolone Derivative
6%
Erythromycin
6%
Health Outcomes
6%
Cohort Effect
6%
Ribotyping
6%
Cephalosporin
6%
Group Sex
6%
In Vitro
6%
Odds Ratio
5%
Fecal Microbiota Transplantation
5%
Inpatient
5%
Ridinilazole
5%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Ridinilazole
22%
Clinical Trial
18%
Antibiotics
16%
Recurrent Disease
16%
Vancomycin
14%
Antibiotic Agent
13%
Pharmacotherapy
12%
Drug Discovery
12%
Carbapenem
12%
Antibiotic Therapy
12%
Kidney Injury
12%
Gastrointestinal Infection
12%
Tazobactam
12%
Ceftolozane
12%
Genetic Susceptibility
12%
Gram Negative Infection
12%
Meropenem
12%
Vaborbactam
12%
Intracellular Bacterium
12%
Toxoid
12%
Feces microflora
9%
Antiinfective Agent
6%
Dysbiosis
6%
Cephalosporin Derivative
6%
Quinolone Derivative
6%
Erythromycin
6%
Clindamycin
6%
Fidaxomicin
6%
Infectious Agent
6%
Microbiome
6%
Microflora
5%
Metronidazole
5%
Antibiotic Prophylaxis
5%
